Background: Subjects with severe compared with mild primary hypertension are at greater risk for decline in glomerular filtration rate (GFR), but additional risk factors are poorly defined.
Methods: Seventy-five subjects referred for assistance with blood pressure control ("severe") and 150 not-referred hypertensive subjects ("mild") were prospectively followed for 7 years. The primary outcome was the change in calculated GFR during follow-up as predicted by various clinical parameters, including urine albumin excretion measured as urine albumin (mg)-to-creatinine (g) (alb/cr) ratio.
Results: Calculated GFR declined faster (more negative slope) in patients with severe hypertension than in those with mild hypertension (-0.188+/- 0.025 versus -0.120+/- 0.008 mL/min/month; P=0.010), despite similar follow-up systolic blood pressure (133.4+/-1.2 versus 131.9+/-0.8 mm Hg). Severe subjects had higher entry alb/cr (241.3+/- 29.1 versus 11.4+/- 0.5) and a greater proportion of cigarette smokers than mild subjects (56 versus 19%). Regression analysis comparing GFR decline to alb/cr showed that GFR changed minimally for alb/cr up to 200 but declined at a progressively faster rate as alb/cr increased above 200. GFR declined faster (more negative slope) in smokers than in nonsmokers (-0.231+/- 0.023 versus -0.102+/- 0.008 mL/min/month; P<0.001). Cigarette smoking increased the risk for GFR decline in subjects with alb/cr <200 and in those with alb/cr >200, but the effect was much more robust for subjects with alb/cr >200.
Conclusions: Urine alb/cr >200 increases the risk for subsequent GFR decline in primary hypertension, and this risk is enhanced by cigarette smoking.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00000441-200509000-00003 | DOI Listing |
Eur J Heart Fail
January 2025
Department of Medicine, University of Chicago Medicine, Chicago, IL, USA.
Aims: This post hoc analysis aimed to assess the efficacy and safety of the non-steroidal mineralocorticoid receptor antagonist finerenone by baseline diuretic use in FIDELITY, a pre-specified pooled analysis of the phase III trials FIDELIO-DKD and FIGARO-DKD.
Methods And Results: Eligible patients with type 2 diabetes (T2D) and chronic kidney disease (CKD; urine albumin-to-creatinine ratio [UACR] ≥30-<300 mg/g and estimated glomerular filtration rate [eGFR] ≥25-≤90 ml/min/1.73 m, or UACR ≥300-≤5000 mg/g and eGFR ≥25 ml/min/1.
J Clin Hypertens (Greenwich)
January 2025
Department of Geriatrics, Medical Center on Aging of Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
The aim of this study was to explore whether 24-h ambulatory central (aortic) blood pressure (BP) has an advantage over office central aortic BP in screening for hypertension-mediated target organ damage (HMOD). A total of 714 inpatients with primary hypertension and the presence of several cardiovascular risk factors or complications involving clinical HMOD were enrolled. Twenty-four hour central aortic BP was measured by means of a noninvasive automated oscillometric device (Mobil-O-Graph).
View Article and Find Full Text PDFJ Am Soc Nephrol
January 2025
Department of Pediatrics, Division of Nephrology, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Background: We have previously studied biomarkers of tubular health (EGF), injury (KIM-1), dysfunction (alpha-1 microglobulin), and inflammation (TNFR-1, TNFR-2, MCP-1, YKL-40, suPAR), and demonstrated that plasma KIM-1, TNFR-1, TNFR-2 and urine KIM-1, EGF, MCP-1, urine alpha-1 microglobulin are each independently associated with CKD progression in children. In this study, we used bootstrapped survival trees to identify a combination of biomarkers to predict CKD progression in children.
Methods: The CKiD Cohort Study prospectively enrolled children 6 months to 16 years old with an eGFR of 30-90 ml/min/1.
Sci Rep
January 2025
Clinical Biochemistry Laboratory, Beaujon Hospital, APHP, Clichy, France.
Inflammatory bowel diseases cause chronic intestinal inflammation, including Crohn's disease (CD) and ulcerative colitis (UC). Prostaglandin E-major urinary metabolite (PGE-MUM) is a urine biomarker for disease activity in IBD. This study evaluated PGE-MUM performance for predicting an active disease in patients with CD and UC.
View Article and Find Full Text PDFClin Nephrol Case Stud
January 2025
Department of Medicine.
Minimal change disease (MCD) accounts for 10 - 15% of idiopathic nephrotic syndromes in adults. Chronic hepatitis C virus (HCV) infection is rarely ascribed as a cause of MCD and was previously associated with interferon-based therapy. MCD in treatment-naïve chronic HCV infection is extremely rare, with only 3 cases reported in the literature.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!